AR056674A1 - ORAL CONTRACEPTION WITH TRIMEGESTONE - Google Patents

ORAL CONTRACEPTION WITH TRIMEGESTONE

Info

Publication number
AR056674A1
AR056674A1 ARP060103101A ARP060103101A AR056674A1 AR 056674 A1 AR056674 A1 AR 056674A1 AR P060103101 A ARP060103101 A AR P060103101A AR P060103101 A ARP060103101 A AR P060103101A AR 056674 A1 AR056674 A1 AR 056674A1
Authority
AR
Argentina
Prior art keywords
trimegestone
oral contraception
contraception
successive days
woman
Prior art date
Application number
ARP060103101A
Other languages
Spanish (es)
Inventor
Oliver Gloger
Heinrich Kugelmann
Mario Popova
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005034498A external-priority patent/DE102005034498A1/en
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR056674A1 publication Critical patent/AR056674A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Abstract

Método para la anticoncepcion que comprende la administracion de trimegestona junto con etinilestradiol a una mujer en edad fértil en al menos 21 días sucesivos, comenzando el día 1 del ciclo menstrual, en el que en al menos uno de los al menos 21 días sucesivos la dosis diaria de trimegestona es superior a 500 ?g.Method for contraception comprising the administration of trimegestone together with ethinyl estradiol to a woman of childbearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, in which at least one of the at least 21 successive days the dose Trimegestone daily is greater than 500 µg.

ARP060103101A 2005-07-20 2006-07-19 ORAL CONTRACEPTION WITH TRIMEGESTONE AR056674A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005034498A DE102005034498A1 (en) 2005-07-20 2005-07-20 Oral contraception with Trimegeston
US11/348,545 US20070021396A1 (en) 2005-07-20 2006-02-06 Oral contraception with trimegestone

Publications (1)

Publication Number Publication Date
AR056674A1 true AR056674A1 (en) 2007-10-17

Family

ID=37075980

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103101A AR056674A1 (en) 2005-07-20 2006-07-19 ORAL CONTRACEPTION WITH TRIMEGESTONE

Country Status (6)

Country Link
EP (1) EP1909799A1 (en)
KR (1) KR20080031435A (en)
AR (1) AR056674A1 (en)
AU (1) AU2006271920A1 (en)
CA (1) CA2615427A1 (en)
WO (1) WO2007009769A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004246A2 (en) * 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
FR2801218B1 (en) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc PHARMACEUTICAL COMPOSITIONS COMPRISING TRIMEGESTONE, THEIR PREPARATION METHODS AND THE PRIMARY PACKAGING CONTAINING THEM

Also Published As

Publication number Publication date
EP1909799A1 (en) 2008-04-16
WO2007009769A1 (en) 2007-01-25
KR20080031435A (en) 2008-04-08
AU2006271920A1 (en) 2007-01-25
CA2615427A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
ECSP088123A (en) ORAL CONTRACEPTION WITH TRIMEGESTONE
CR7611A (en) USE OF CILOTIOCARBAMATE DERIVATIVES IN TREATMENT OF CONDITIONS RELATED TO HORMONE
AR054525A1 (en) COMPOSITIONS AND METHODS FOR THE PROCESSING OF SYMPTOMS RELATED TO THE CYCLE
AR057060A1 (en) TANAPROGET COMPOSITIONS CONTAINING ETHYL ESTRADIOL
ES2693085T1 (en) Use of estriol in low doses
RS51569B (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
AR077199A1 (en) PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE FOR EMERGENCY ANTI-CONCEPTION
UY33343A (en) ORAL SOLID DOSAGE FORMS WITH VERY LOW DOSE FOR HRT
AR032204A1 (en) CYCLODEXTRINE-DROSPIRENONE INCLUSION COMPLEXES
RS53876B1 (en) Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis
BR0313921A (en) Estrogen replacement regimen
HN2008000621A (en) METHOD FOR PREVENTIVE HORMONAL ANTICOPCEPTION UNDER DEMAND
EA201400202A1 (en) APPLICATION OF ESTHETROL AS AN EMERGENCY CONTRACTIVE
UY30461A1 (en) PHARMACEUTICAL COMPOSITION FOR ANTI-CONCEPTION AND TO REDUCE THE RISK OF CONGENITAL MALFORMATIONS.
PE20061314A1 (en) ASSOCIATION BETWEEN FERROQUINE AND A DERIVATIVE OF ARTEMISININ FOR THE TREATMENT OF MALARIA
PE20211588A1 (en) COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS ASSOCIATED WITH MENOPAUSE
AR065816A1 (en) ORAL CONTRACEPTIVE REGIME
ES2563068T3 (en) Multiple sclerosis (MS) treatment with Campath-1H
GT200900296A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVE AGENT.
SV2009003168A (en) OXAZOLIDONE DERIVATIVES AS PR MODULATORS
ES2574999T3 (en) Method for contraception on demand using levonorgestrel or norgestrel
UY29861A1 (en) USE OF ESTRADIOL VALERATE IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY OF THE UNITED DYSFUNCTIONAL UTERINE HEMORRAGY WITH AN ORAL ANTICONCEPTION
AR056674A1 (en) ORAL CONTRACEPTION WITH TRIMEGESTONE
CL2008002465A1 (en) Topical anhydrous pharmaceutical composition, comprising niacin derivatives and an acceptable carrier, its application allows improved sexual well-being.
AR057155A1 (en) METHOD OF ADMINISTRATION OF 5- (2-CHLOROPHENIL) -1,2-DIHIDRO-7-FLUOR-8-METOXI-3-METHYL-PIRAZOLO [3,4-B] [1,4] BENZODIAZEPINA

Legal Events

Date Code Title Description
FB Suspension of granting procedure